Dr. Muhammad Imran Khan


Dr. Muhammad Imran Khan

Assistant Professor


Muhammad Imran Khan (Assistant Professor), joined Pak-Austria Fachhochschule: Institute of Applied Sciences and Technology (PAF-IAST) as an Assistant Professor of Biomedical Sciences in the Department of Biomedical Sciences in Dec, 2021. He received his Pharm.D degree from Gomal University and Ph.D. from Tehran University of Medical Sciences in the field of neuropharmacology. Prior to continuing his services at PAF-IAST, he served at many national and international universities in capacity of Research Associate, Lecturer, and Assistant Professor. He has extensively published in the area of brain behavior, molecular genetics and biosignaling. He was awarded with the title of “Junior Scientist in Medical Sciences” by International Professor Yalda Organization in 2016. In same year the International Campus of Tehran University of Medical Sciences awarded the “Best researcher award” due to his significant contribution in the field of science. He is a member of IBRO neuroscience society and International Society for Neurochemistry. He is keen and has various research collaboration with diverse international research groups form Iran, Brazil, Tajikistan and USA.

Professional Appointments

  • Assistant Professor, Department of Biomedical Sciences PAF-IAST, 2020 to current
  • Assistant Professor of Pharmacology, Riphah International University, Islamabad, September, 2020 to December, 2021
  • Head of Department of Allied Health Sciences/Assistant Professor, Bashir Institute of Health Sciences, Islamabad, Pakistan, August 2019 to September 2020
  • Assistant Professor, Department of Pharmacy, Kohat University of Science and Technology, KPK, February 2014 to January 2017
  • Research Associate, Brain and Spinal Cord Injury Research Center, Imam Khomeini Hospital, Tehran, Iran, September 2012 to September 2016


  • PhD Pharmacology, Tehran University of Medical Sciences, Tehran, Iran, 2016
  • Doctor of Pharmacy, Gomal University, KPK, Pakistan,2009
  • F.Sc. Premedical (HSSC), BISE, Bannu, 2004


  • Khan M.I, Ostadhadi S, Mumtaz F, Momeny M, Moghaddaskho F, Hassanipour M, Ejtemaei-Mehr S, Dehpour AR. Thalidomide attenuates the development and expression of antinociceptive tolerance to μ-opioid agonist morphine through l-arginine-iNOS and nitric oxide pathway. Biomedicine & Pharmacotherapy. 2017 Jan 1;85:493-502.
  • Khan MI, Ostadhadi S, Zolfaghari S, Mehr SE, Hassanzadeh G, Dehpour AR. The involvement of NMDA receptor/NO/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test. Neuroscience letters. 2016 Jan 26;612:52-61.
  • Khan, M.I., Momeny, M., Ostadhadi, S., Jahanabadi, S., Ejtemaei-Mehr, S., Sameem, B., Zarrinrad, G. and Dehpour, A.R., 2018. Thalidomide attenuates development of morphine dependence in mice by inhibiting PI3K/Akt and nitric oxide signaling pathways. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 82, pp.39-48.
  • Ostadhadi, S., Khan, M.I., Norouzi-Javidan, A. and Dehpour, A.R., 2016. Antidepressant effect of pramipexole in mice forced swimming test: a cross talk between dopamine receptor and NMDA/nitric oxide/cGMP pathway. Biomedicine & Pharmacotherapy, 81, pp.295-304.
  • Mumtaz F, Khan MI, Zubair M, Dehpour AR. Neurobiology and consequences of social isolation stress in animal model—A comprehensive review. Biomedicine & Pharmacotherapy. 2018 Sep 1;105:1205-22.
situs togel situs togel situs togel situs toto